These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 36327298)

  • 21. Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis.
    Hutten NRPW; Arkell TR; Vinckenbosch F; Schepers J; Kevin RC; Theunissen EL; Kuypers KPC; McGregor IS; Ramaekers JG
    Psychopharmacology (Berl); 2022 Nov; 239(11):3731-3741. PubMed ID: 36227352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses.
    Lawn W; Freeman TP; Pope RA; Joye A; Harvey L; Hindocha C; Mokrysz C; Moss A; Wall MB; Bloomfield MA; Das RK; Morgan CJ; Nutt DJ; Curran HV
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3537-52. PubMed ID: 27585792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model.
    Casey SL; Mitchell VA; Sokolaj EE; Winters BL; Vaughan CW
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected].
    Morgan CJ; Schafer G; Freeman TP; Curran HV
    Br J Psychiatry; 2010 Oct; 197(4):285-90. PubMed ID: 20884951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multivariate classification of cannabis chemovars based on their terpene and cannabinoid profiles.
    Birenboim M; Chalupowicz D; Maurer D; Barel S; Chen Y; Fallik E; Paz-Kagan T; Rapaport T; Sadeh A; Kengisbuch D; Shimshoni JA
    Phytochemistry; 2022 Aug; 200():113215. PubMed ID: 35483556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.
    Hindelang P; Scharinger A; Richling E; Walch SG; Lachenmeier DW
    Front Biosci (Landmark Ed); 2022 Jul; 27(8):228. PubMed ID: 36042166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How should policymakers regulate the tetrahydrocannabinol content of cannabis products in a legal market?
    Hall W; Leung J; Carlini BH
    Addiction; 2023 Jun; 118(6):998-1003. PubMed ID: 36662648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigating Relationships Between Alcohol and Cannabis Use in an Online Survey of Cannabis Users: A Focus on Cannabinoid Content and Cannabis for Medical Purposes.
    Karoly HC; Mueller RL; Andrade CC; Hutchison KE
    Front Psychiatry; 2020; 11():613243. PubMed ID: 33408657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Model-based analysis on systemic availability of co-administered cannabinoids after controlled vaporised administration.
    Liu Z; Galettis P; Broyd SJ; van Hell H; Greenwood LM; de Krey P; Steigler A; Zhu X; Schneider J; Solowij N; Martin JH
    Intern Med J; 2020 Jul; 50(7):846-853. PubMed ID: 31264294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores.
    Spindle TR; Sholler DJ; Cone EJ; Murphy TP; ElSohly M; Winecker RE; Flegel RR; Bonn-Miller MO; Vandrey R
    JAMA Netw Open; 2022 Jul; 5(7):e2223019. PubMed ID: 35857320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration.
    Sholler DJ; Spindle TR; Cone EJ; Goffi E; Kuntz D; Mitchell JM; Winecker RE; Bigelow GE; Flegel RR; Vandrey R
    J Anal Toxicol; 2022 May; 46(5):494-503. PubMed ID: 34089060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Individuality of Response to Cannabinoids: Challenges in Safety and Efficacy of Cannabis Products.
    Kitdumrongthum S; Trachootham D
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined effect of alcohol and cannabis on simulated driving.
    Fares A; Wickens CM; Mann RE; Di Ciano P; Wright M; Matheson J; Hasan OSM; Rehm J; George TP; Samokhvalov AV; Shuper PA; Huestis MA; Stoduto G; Brown T; Stefan C; Rubin-Kahana DS; Le Foll B; Brands B
    Psychopharmacology (Berl); 2022 May; 239(5):1263-1277. PubMed ID: 33544195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applications of Capillary Electrophoresis for the Determination of Cannabinoids in Different Matrices.
    Blebea NM; Hancu G; Vlad RA; Pricopie A
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary study of the interactive effects of THC and ethanol on self-reported ability and simulated driving, subjective effects, and cardiovascular responses.
    Schnakenberg Martin AM; Flynn LT; Sefik E; Luddy C; Cortes-Briones J; Skosnik PD; Pittman B; Ranganathan M; D'Souza DC
    Psychopharmacology (Berl); 2023 Jun; 240(6):1235-1246. PubMed ID: 37045988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations.
    Moore CF; Weerts EM
    Psychopharmacology (Berl); 2022 May; 239(5):1397-1408. PubMed ID: 34652500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potency levels of regulated cannabis products in Michigan 2021-2022.
    Glinn MA; Michaud GP
    J Forensic Sci; 2023 Nov; 68(6):1894-1905. PubMed ID: 37501559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 'Synthetic cannabis': A dangerous misnomer.
    Darke S; Banister S; Farrell M; Duflou J; Lappin J
    Int J Drug Policy; 2021 Dec; 98():103396. PubMed ID: 34343944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled human drug administration studies are necessary to define the THC-sparing effects of CBD and other cannabis constituents.
    Pabon E; Cooper ZD
    Neuropsychopharmacology; 2023 May; 48(6):850-851. PubMed ID: 36725865
    [No Abstract]   [Full Text] [Related]  

  • 40. Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and Medicines.
    Arellano AL; Papaseit E; Romaguera A; Torrens M; Farré M
    CNS Neurol Disord Drug Targets; 2017; 16(5):554-566. PubMed ID: 28412920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.